Emcure Pharmaceuticals Limited header image

Emcure Pharmaceuticals Limited

544210

Equity

ISIN INE168P01015 / Valor 136422285

Bombay Stock Exchange Ltd. (Mumbai) (2026-09-07)

INR 1,927.15-0.07%

Emcure Pharmaceuticals Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Emcure Pharmaceuticals Limited is a Pune‑headquartered, publicly listed Indian drug maker founded by Satish Mehta that develops, manufactures and sells generic and branded pharmaceuticals and active pharmaceutical ingredients for domestic and international markets. The company operates multiple manufacturing and R&D facilities and supplies a range of dosage forms — including oral solids, sterile injectables and specialty therapies — with commercial focus areas that have included oncology, hormones, and other therapeutic segments; it also provides contract manufacturing and development services and markets products through subsidiaries and export channels across North America, Europe and emerging markets.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

40.4%1Y

%3Y

%5Y

Performance

32.5%1Y

36.1%3Y

36.1%5Y

Volatility

3857 M

Market cap (USD)

10,479

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

SHL Telemedicine Ltd

SHL Telemedicine Ltd Valor: 1128957

Annual Return

-50%0%+50%

Risk level

110

-0.47%CHF 1.06

Attendo AB

Attendo AB Valor: 30491576

Annual Return

-50%0%+50%

Risk level

110

0.41%SEK 122.00

Galapagos NV

Galapagos NV Valor: 2130343

Annual Return

-50%0%+50%

Risk level

110

-0.73%EUR 24.42

Surgery Partners Inc

Surgery Partners Inc Valor: 29308003

Annual Return

-50%0%+50%

Risk level

110

0.64%USD 14.26

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc Valor: 1806798

Annual Return

-50%0%+50%

Risk level

110

0.61%USD 266.11

Molina Healthcare Inc

Molina Healthcare Inc Valor: 1538184

Annual Return

-50%0%+50%

Risk level

110

-1.04%USD 200.80

Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc Valor: 25419823

Annual Return

-50%0%+50%

Risk level

110

-1.08%USD 59.75

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc Valor: 18393960

Annual Return

-50%0%+50%

Risk level

110

-1.00%USD 43.53

Robertet SA

Robertet SA Valor: 510354

Annual Return

-50%0%+50%

Risk level

110

-0.75%EUR 791.00

Boston Scientific Corp

Boston Scientific Corp Valor: 913577

Annual Return

-50%0%+50%

Risk level

110

1.81%USD 47.80

SIX

FactSet

Clearbit

Logos provided by Clearbit